The present study demonstrated that CXCL10 was significantly enriched in the Toll-like receptor signaling pathway, leading us to speculate that it is a key gene that participates in the pathogenesis of GDM by regulating the progress of the Toll-like receptor signaling pathway. The gene discussed is CXCL10; the disease is gestational diabetes.